A Relação do HPV com o Desenvolvimento do Câncer de Orofaringe no Brasil

Resumo

A Relação do HPV com o desenvolvimento do câncer de orofaringe no Brasil, busca explorar a relação entre o papilomavírus humano (HPV) e o câncer de orofaringe no contexto brasileiro. Observando a importância sobre o assunto que este trabalho teve como principal objetivo analisar a relação entre a infecção por HPV e o desenvolvimento do câncer de orofaringe no Brasil. A pesquisa baseou-se em uma revisão integrativa da literatura, selecionando artigos, livros e monografias entre os anos de 2015 a 2024, com análise focada em estudos observacionais e ensaios clínicos, utilizando as seguintes bases de dados: National Library of Medicine (PubMed), Biblioteca Virtual em Saúde (BVS), National Library of Medicine (MEDLINE), Literatura Latino-Americana e do Caribe em Ciências da Saúde (LILACS) e Scientific Electronic Library Online (SCIELO). Um total de 789 obras foram identificadas, e distribuídas entre as plataformas digitais disponíveis. Os resultados mostraram que a relação entre o HPV e o câncer de orofaringe no Brasil revela tendências importantes, tanto no aumento da prevalência da doença quanto nas implicações clínicas e sociais associadas. O crescimento dos casos de carcinomas de orofaringe induzidos pelo HPV, especialmente entre jovens, reflete uma transição epidemiológica significativa, destacando o vírus como um fator etiológico preponderante. Além disso, pacientes HPV-positivos apresentam prognósticos mais favoráveis, com melhores taxas de sobrevida, indicando que o status de HPV deve ser considerado no manejo e no tratamento da doença.

Referências

1. ARAÚJO, M. G., MAGALHÃES, G. M., GARCIA, L. C., VIEIRA, É. C., CARVALHO-LEITE, M. D. L. R. D., GUEDES, A. C. M. Update on human papillomavirus-Part II: complementary diagnosis, treatment and prophylaxis. Anais Brasileiros de Dermatologia, v. 96, p. 125-138, 2021.
2. BONANNI, P., BECHINI, A., DONATO, R., CAPEI, R., SACCO, C., LEVI, M., BOCCALINI, S. Human papilloma virus vaccination: impact and recommendations across the world. Therapeutic advances in vaccines, v. 3, n. 1, p. 3-12, 2015.
3. BUEXM, L. A.; SOARES-LIMA, S. C.; BRENNAN, P.; FERNANDES, P. V.; LOPES, M. D. S. A.; DE CARVALHO, F. N.; PINTO, L. F. R. HPV impact on oropharyngeal cancer patients treated at the largest cancer center from Brazil. Cancer Letters, v. 477, p. 70-75, 2020.
4. CUNHA, A. R. D.; PRASS, T. S.; HUGO, F. N. Mortality from oral and oropharyngeal cancer in Brazil, between 2000 and 2013: trends by sociodemographic strata. Ciência & Saúde Coletiva, v. 25, p. 3075-3086, 2020.
5. CUNHA, A. R. da; PRASS, Taiane Schaedler; HUGO, Fernando Neves. Mortality from oral and oropharyngeal cancer in Brazil, between 2000 and 2013: trends by sociodemographic strata. Ciência & Saúde Coletiva, v. 25, p. 3075-3086, 2020.
6. CUNHA, L. P. et al. The relation between human papillomavirus (HPV) and oropharynx cancer: state of the art. RGO-Revista Gaúcha de Odontologia, v. 72, p. e20240014, 2024.
7. CUNHA, L. P.; CONCEIÇÃO, E. G.; MARQUES, M. V. C.; SOUZA, M. F. D.; NÉRI, J. V. D. S.; DANTAS, J. B. D. L. The relation between human papillomavirus (HPV) and oropharynx cancer: state of the art. RGO - Revista Gaúcha de Odontologia, v. 72, p. e20240014, 2024.
8. DA CUNHA, A. R. et al. The impact of inequalities and health expenditure on mortality due to oral and oropharyngeal cancer in Brazil. Scientific reports, v. 11, n. 1, p. 12845, 2021.
9. DAY, A. T., FAKHRY, C., TIRO, J. A., DAHLSTROM, K. R., STURGIS, E. M. Considerations in human papillomavirus–associated oropharyngeal cancer screening: a review. JAMA Otolaryngology–Head & Neck Surgery, v. 146, n. 7, p. 656-664, 2020.
10. DE OLIVEIRA, M. L. W. D. R. Impact of Preventive Campaigns in Dermatology: A Brazilian Experience. In: Dermatology in Public Health Environments: A Comprehensive Textbook. Cham: Springer International Publishing, 2023. p. 41-63.
11. DOMINGUES, C. M. A. S., MARANHÃO, A. G. K., TEIXEIRA, A. M., FANTINATO, F. F., DOMINGUES, R. A. The Brazilian National Immunization Program: 46 years of achievements and challenges. Cadernos de saude publica, v. 36, p. e00222919, 2020.
12. DOS SANTOS MENEZES, F., FERNANDES, G. A., ANTUNES, J. L. F., VILLA, L. L., TOPORCOV, T. N. Global incidence trends in head and neck cancer for HPV-related and-unrelated subsites: A systematic review of population-based studies. Oral oncology, v. 115, p. 105177, 2021.
13. DOS SANTOS, J. I. D. O.; FERREIRA, J. S.; MUNHOZ, I. G. A.; DE LEMOS, D. L. P.; TENÓRIO, D. D. P. Q.; RODAS, L. O.; PANJWANI, C. M. B. R. G. Perspectives of oral cancer’s epidemiological panorama in Brazil. Rev. Med., v. 99, p. 556-562, 2020.
14. FIORILLO, L., CERVINO, G., SURACE, G., DE STEFANO, R., LAINO, L., D’AMICO, C., CICCIÙ, M. Human papilloma virus: current knowledge and focus on oral health. BioMed research international, v. 2021, n. 1, p. 6631757, 2021.
15. GOUGOUSIS, S.; MOUCHTAROPOULOU, E.; BESLI, I.; VROCHIDIS, P.; SKOUMPAS, I.; CONSTANTINIDIS, I. HPV-related oropharyngeal cancer and biomarkers based on epigenetics and microbiome profile. Frontiers in Cell and Developmental Biology, v. 8, p. 625330, 2021.
16. JALIL, A. T., KAREVSKIY, A. The cervical cancer (CC) epidemiology and human papillomavirus (HPV) in the middle east. International Journal of Environment, Engineering and Education, v. 2, n. 2, p. 7-12, 2020.
17. LAURITZEN, B. B., GRØNLUND, M. W., JAKOBSEN, K. K., JUSTESEN, M. M., GARSET‐ZAMANI, M., CARLANDER, A. L. F., VON BUCHWALD, C. Epidemiological trends and survival of oropharyngeal cancer in a high HPV‐prevalent area: a Danish population‐based study from 2000 to 2020. International Journal of Cancer, 2024.
18. LECHNER, M., LIU, J., MASTERSON, L., FENTON, T. R. HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nature reviews Clinical oncology, v. 19, n. 5, p. 306-327, 2022.
19. LECHNER, M., LIU, J., MASTERSON, L., FENTON, T. R. HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nature reviews Clinical oncology, v. 19, n. 5, p. 306-327, 2022.
20. LECHNER, M., LIU, J., MASTERSON, L., FENTON, T. R. HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nature reviews Clinical oncology, v. 19, n. 5, p. 306-327, 2022.
21. LECHNER, M.; LIU, J.; MASTERSON, L.; FENTON, T. R. HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nature Reviews Clinical Oncology, v. 19, n. 5, p. 306-327, 2022.
22. LOUREDO, B. V. R., PRADO-RIBEIRO, A. C., BRANDÃO, T. B., EPSTEIN, J. B., MIGLIORATI, C. A., PIÑA, A. R., SANTOS-SILVA, A. R. State-of-the-science concepts of HPV-related oropharyngeal squamous cell carcinoma: a comprehensive review. Oral surgery, oral medicine, oral pathology and oral radiology, v. 134, n. 2, p. 190-205, 2022.
23. MELO, B. A. de C. et al. Human papillomavirus infection and oral squamous cell carcinoma-a systematic review. Brazilian journal of otorhinolaryngology, v. 87, p. 346-352, 2021.
24. MENEZES, F. D. S.; LATORRE, M. D. R. D. D. O.; CONCEIÇÃO, G. M. D. S.; CURADO, M. P.; ANTUNES, J. L. F.; TOPORCOV, T. N. The emerging risk of oropharyngeal and oral cavity cancer in HPV-related subsites in young people in Brazil. PLoS One, v. 15, n. 5, p. e0232871, 2020.
25. MENEZES, F. dos S. et al. The emerging risk of oropharyngeal and oral cavity cancer in HPV-related subsites in young people in Brazil. PLoS One, v. 15, n. 5, p. e0232871, 2020.
26. MENEZES, S. A. F.; MIRANDA, Y. M. S.; DA SILVA, Y. M.; CARVALHO, T. R. B.; ALVES, F. R. S.; SILVESTRE, R. V. D.; MACHADO, L. F. A. Prevalence and Genotyping of HPV in Oral Squamous Cell Carcinoma in Northern Brazil. Pathogens, v. 11, n. 10, p. 1106, 2022.
27. MORAND, G. B.; CARDONA, I.; CRUZ, S. B. S. C.; MLYNAREK, A. M.; HIER, M. P.; ALAOUI-JAMALI, M. A.; DA SILVA, S. D. Therapeutic vaccines for HPV-associated oropharyngeal and cervical cancer: the next de-intensification strategy? International Journal of Molecular Sciences, v. 23, n. 15, p. 8395, 2022.
28. Näsman, A., Du, J., Dalianis, T. A global epidemic increase of an HPV‐induced tonsil and tongue base cancer–potential benefit from a pan‐gender use of HPV vaccine. Journal of internal medicine, v. 287, n. 2, p. 134-152, 2020.
29. OLIVEIRA, A. C. et al. Human papillomavirus prevalence in oral and oropharyngeal squamous cell carcinoma in South America: A systematic review and meta-analysis. Oncology Reviews, v. 16, n. 1, 2022.
30. OLIVEIRA, A. C.; DE LIMA, I. C. C.; MARQUES, V. M. F.; DE ARAÚJO, W. H. A.; DE CAMPOS FERREIRA, C. Human papillomavirus prevalence in oral and oropharyngeal squamous cell carcinoma in South America: A systematic review and meta-analysis. Oncology Reviews, v. 16, n. 1, 2022.
31. PERES, K. C., BUENDGENS, F. B., PRATES, E. A., BONETTI, N. R., SOARES, L., VARGAS-PELÁEZ, C. M., & FARIAS, M. R. Vaccines in Brazil: historical analysis of the Sanitary registration and vaccine availability in the Brazilian Unified Health System. Ciência & Saúde Coletiva, v. 26, p. 5509-5522, 2021.
32. PIRES, R. C. et al. Progressive increase trend in HPV-related oropharyngeal squamous cell carcinoma in Brazil. International Archives of Otorhinolaryngology, v. 26, n. 01, p. e132-e136, 2022.
33. SANTACROCE, L.; DI COSOLA, M.; BOTTALICO, L.; TOPI, S.; CHARITOS, I. A.; BALLINI, A.; DIPALMA, G. Focus on HPV infection and the molecular mechanisms of oral carcinogenesis. Viruses, v. 13, n. 4, p. 559, 2021.
34. SANTOS CARVALHO, R.; SCAPULATEMPO-NETO, C.; CURADO, M. P.; DE CASTRO CAPUZZO, R.; MARSICO TEIXEIRA, F.; CARDOSO PIRES, R.; DE CARVALHO, A. C. HPV-induced oropharyngeal squamous cell carcinomas in Brazil: prevalence, trend, clinical, and epidemiologic characterization. Cancer Epidemiology, Biomarkers & Prevention, v. 30, n. 9, p. 1697-1707, 2021.
35. SHIGEISHI, H. Association between human papillomavirus and oral cancer: a literature review. International Journal of Clinical Oncology, v. 28, n. 8, p. 982-989, 2023.
36. SHIGEISHI, Hideo. Association between human papillomavirus and oral cancer: a literature review. International Journal of Clinical Oncology, v. 28, n. 8, p. 982-989, 2023.
37. SKALETZ-ROROWSKI, A., POTTHOFF, A., NAMBIAR, S., WACH, J., KAYSER, A., KASPER, A., BROCKMEYER, N. H. Age specific evaluation of sexual behavior, STI knowledge and infection among asymptomatic adolescents and young adults. Journal of Infection and Public Health, v. 13, n. 8, p. 1112-1117, 2020.
38. SPIOTTO, M. T.; TANIGUCHI, C. M.; KLOPP, A. H.; COLBERT, L. E.; LIN, S. H.; WANG, L.; FRANK, S. J. Biology of the radio-and chemo-responsiveness in HPV malignancies. Seminars in Radiation Oncology, v. 31, n. 4, p. 274-285, 2021.
39. SUEHIRO, T. T., GIMENES, F., SOUZA, R. P., TAURA, S. K. I., CESTARI, R. C. C., IRIE, M. M. T., SILVA, V. R. S. D. High molecular prevalence of HPV and other sexually transmitted infections in a population of asymptomatic women who work or study at a Brazilian university. Revista do Instituto de Medicina Tropical de São Paulo, v. 63, p. e1, 2021.
40. SZYMONOWICZ, K. A.; CHEN, J. Biological and clinical aspects of HPV-related cancers. Cancer Biology & Medicine, v. 17, n. 4, p. 864, 2020.
41. TAVARES FILHO, D. S., ROCHA, C. M. R., BACHA, E., ANDRADE, Á. N. M., PEREIRA, D. D. P., NUNES, L. M., SOBRINHO, F. E. R. A. Current HPV vaccination strategies in Brazil. Health, v. 15, n. 2, p. 107-121, 2023.
42. WENDLAND, E. M. et al. STOP HPV study protocol: a nationwide case–control study of the association between oropharyngeal cancer and human papillomavirus (HPV) infection in Brazil. BMJ open, v. 10, n. 1, p. e031602, 2020.
43. WIERZBICKA, M., KLUSSMANN, J. P., SAN GIORGI, M. R., WUERDEMANN, N., DIKKERS, F. G. Oral and laryngeal HPV infection: Incidence, prevalence and risk factors, with special regard to concurrent infection in head, neck and genitals. Vaccine, v. 39, n. 17, p. 2344-2350, 2021.